IMPAIRMENT OF LONG LIVED ASSETS	9 Months Ended	12 Months Ended
Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
IMPAIRMENT OF LONG LIVED ASSETS	NOTE 13 - IMPAIRMENT OF LONG LIVED ASSETS In the fourth quarter 2021 the Company determined that its fixed assets were obsolete and wrote off the undepreciated balance of $1,958. In March 2021, when the Company’s new website was placed in service, the remaining unamortized cost of the Company’s legacy website was written off, for a total charge of $15,000.	NOTE 14 - IMPAIRMENT OF LONG-LIVED ASSETS In the fourth quarter the Company determined that its fixed assets were obsolete and wrote off the undepreciated balance of $1,958. In March 2021, when the Company’s new website was placed in service, the remaining unamortized cost of the Company’s old website was written off, for a total of $15,000. During the 4^th quarter 2020, the Company elected to abandon certain intangible assets it had been attempting to commercialize under previous management. As such the Company recorded a $34,516 impairment charge.

IMPAIRMENT OF LONG LIVED ASSETS

9 Months Ended

12 Months Ended

Sep. 30, 2022

Dec. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

NOTE 13 - IMPAIRMENT OF LONG LIVED ASSETS

In the fourth quarter 2021 the Company determined that its fixed assets were obsolete and wrote off the undepreciated balance of $1,958.

In March 2021, when the Company’s new website was placed in service, the remaining unamortized cost of the Company’s legacy website was written off, for a total charge of $15,000.

NOTE 14 - IMPAIRMENT OF LONG-LIVED ASSETS

In the fourth quarter the Company determined that its fixed assets were obsolete and wrote off the undepreciated balance of $1,958.

In March 2021, when the Company’s new website was placed in service, the remaining unamortized cost of the Company’s old website was written off, for a total of $15,000.

During the 4^th quarter 2020, the Company elected to abandon certain intangible assets it had been attempting to commercialize under previous management. As such the Company recorded a $34,516 impairment charge.

Curative Biotechnology Inc S-1/A